Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer-Reference-Cited by-同舟云学术

Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer

Published:2017-11-07 Issue:41 Volume:23 Page:7407-7414
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:
Short-container-title:WJG

Author:

Cho Jang Ho,Lim Jae Yun,Cho Jae Yong

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference24 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Global cancer statistics

3. National Cancer Information Center. Cancer registry. Goyang: National Cancer Information Center, c2012 [cited 2012 July 22]. Available from: URL: http://www. cancer.go.kr/cms/statics/ incidence/index.html

4. Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggregate Data

5. HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aggressive HER2-Positive Gastric Cancer in a Young Patient, Refractory in Trastuzumab and Progressive with Trastuzumab-Emtansine Treatment;International Journal of Biomedicine;2024-03-01

2. HER2 becomes a novel survival biomarker for gastric cancer patients: a pooled analysis;Therapeutic Advances in Medical Oncology;2024-01

3. Development of a nomogram based on body composition analysis of quantitative computed tomography combined with clinical prognostic factors to predict disease-free survival after surgery and adjuvant chemotherapy in patients with gastric cancer;Quantitative Imaging in Medicine and Surgery;2023-12

4. Engineered Ultrasmall Nanoparticle Drug‐Immune Conjugates with “Hit and Run” Tumor Delivery to Eradicate Gastric Cancer;Advanced Therapeutics;2022-11-14

5. The Role of Serum CD26 in the Diagnosis of Gastric Cancer;International Journal of General Medicine;2022-09